OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - QIAGEN Share Price

Certificat

DE000SV2EAG7

Real-time Boerse Frankfurt Warrants 13:44:15 03/07/2024 BST
0.73 EUR +5.80% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - QIAGEN
Current month+2.99%
1 month+30.19%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/07/24 0.73 +5.80%
02/07/24 0.69 -6.76%
01/07/24 0.74 +10.45%
28/06/24 0.67 +3.08%
27/06/24 0.65 -4.41%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 01:44 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying QIAGEN N.V.
IssuerLogo Issuer Société Générale Société Générale
WKN SV2EAG
ISINDE000SV2EAG7
Date issued 21/03/2023
Strike 45.07
Maturity Unlimited
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.22
Lowest since issue 0.19
Spread 0.01
Spread %1.35%

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
40.7 USD
Average target price
50.37 USD
Spread / Average Target
+23.75%
Consensus